Tonix Pharmaceuticals Holding (TNXP) Gross Margin (2023 - 2025)
Historic Gross Margin for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to 58.45%.
- Tonix Pharmaceuticals Holding's Gross Margin rose 135500.0% to 58.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 34.31%, marking a year-over-year increase of 135700.0%. This contributed to the annual value of 23.07% for FY2024, which is 158900.0% down from last year.
- Tonix Pharmaceuticals Holding's Gross Margin amounted to 58.45% in Q3 2025, which was up 135500.0% from 63.76% recorded in Q2 2025.
- Tonix Pharmaceuticals Holding's Gross Margin's 5-year high stood at 61.18% during Q1 2025, with a 5-year trough of 63.76% in Q2 2025.
- In the last 3 years, Tonix Pharmaceuticals Holding's Gross Margin had a median value of 40.49% in 2023 and averaged 23.71%.
- The largest annual percentage gain for Tonix Pharmaceuticals Holding's Gross Margin in the last 5 years was 280600bps (2025), contrasted with its biggest fall of -112700bps (2025).
- Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's Gross Margin stood at 37.36% in 2023, then surged by 45bps to 54.18% in 2024, then increased by 8bps to 58.45% in 2025.
- Its last three reported values are 58.45% in Q3 2025, 63.76% for Q2 2025, and 61.18% during Q1 2025.